Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy
Authors
Keywords
-
Journal
PHARMACOGENOMICS JOURNAL
Volume 18, Issue 2, Pages 301-307
Publisher
Springer Nature
Online
2017-05-09
DOI
10.1038/tpj.2017.19
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacogenomics and the treatment of acute myeloid leukemia
- (2016) Juan Eduardo Megías-Vericat et al. PHARMACOGENOMICS
- Evidence for association of SNPs inABCB1andCBR3, but notRAC2, NCF4, SLC28A3orTOP2B, with chronic cardiotoxicity in a cohort of breast cancer patients treated with anthracyclines
- (2016) Daniel L Hertz et al. PHARMACOGENOMICS
- Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients
- (2015) Christof Vulsteke et al. BREAST CANCER RESEARCH AND TREATMENT
- Association of NADPH oxidase polymorphisms with anthracycline-induced cardiotoxicity in the RICOVER-60 trial of patients with aggressive CD20+ B-cell lymphoma
- (2015) Annegret Reichwagen et al. PHARMACOGENOMICS
- Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma
- (2014) Heather L. Gustafson et al. AMERICAN JOURNAL OF HEMATOLOGY
- Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel
- (2014) C. Vulsteke et al. BREAST CANCER RESEARCH AND TREATMENT
- Heterozygote advantage of methylenetetrahydrofolate reductase polymorphisms on clinical outcomes in advanced non-small cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy
- (2014) Xiaoying Li et al. TUMOR BIOLOGY
- Association of Anthracycline-Related Cardiac Histological Lesions With NADPH Oxidase Functional Polymorphisms
- (2013) A. Cascales et al. ONCOLOGIST
- Pretreatment prognostic factors for overall survival in primary resistant acute myeloid leukemia
- (2011) N. Colovic et al. BIOMEDICINE & PHARMACOTHERAPY
- Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma
- (2011) Rachael E. Windsor et al. CANCER
- Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children
- (2011) Henk Visscher et al. JOURNAL OF CLINICAL ONCOLOGY
- A Functional Polymorphism in the NAD(P)H Oxidase Subunit CYBA Is Related to Gene Expression, Enzyme Activity, and Outcome in Non-Hodgkin Lymphoma
- (2010) M. Hoffmann et al. CANCER RESEARCH
- Association of p22phox gene C242T polymorphism with coronary artery disease: A meta-analysis
- (2010) Shengxia Fang et al. THROMBOSIS RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started